nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—CYP1A2—Clobetasol propionate—psoriasis	0.102	0.225	CbGbCtD
Asenapine—CYP1A2—Methoxsalen—psoriasis	0.0536	0.118	CbGbCtD
Asenapine—CYP2D6—Hydroxyurea—psoriasis	0.0483	0.106	CbGbCtD
Asenapine—CYP3A4—Calcitriol—psoriasis	0.0361	0.0796	CbGbCtD
Asenapine—CYP2D6—Cholecalciferol—psoriasis	0.0293	0.0645	CbGbCtD
Asenapine—CYP3A4—Methoxsalen—psoriasis	0.0281	0.0619	CbGbCtD
Asenapine—CYP2D6—Cyclosporine—psoriasis	0.0192	0.0424	CbGbCtD
Asenapine—CYP3A4—Cholecalciferol—psoriasis	0.0186	0.041	CbGbCtD
Asenapine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0161	0.0355	CbGbCtD
Asenapine—CYP3A4—Triamcinolone—psoriasis	0.0161	0.0355	CbGbCtD
Asenapine—CYP3A4—Betamethasone—psoriasis	0.0138	0.0305	CbGbCtD
Asenapine—CYP3A4—Prednisolone—psoriasis	0.0137	0.0301	CbGbCtD
Asenapine—CYP3A4—Hydrocortisone—psoriasis	0.0129	0.0285	CbGbCtD
Asenapine—CYP3A4—Prednisone—psoriasis	0.0129	0.0284	CbGbCtD
Asenapine—CYP2D6—Dexamethasone—psoriasis	0.0127	0.0279	CbGbCtD
Asenapine—CYP3A4—Cyclosporine—psoriasis	0.0122	0.0269	CbGbCtD
Asenapine—CYP3A4—Dexamethasone—psoriasis	0.00805	0.0177	CbGbCtD
Asenapine—Depression—Prednisone—psoriasis	0.000353	0.000779	CcSEcCtD
Asenapine—Hypertension—Mycophenolate mofetil—psoriasis	0.000352	0.000778	CcSEcCtD
Asenapine—Dry mouth—Cyclosporine—psoriasis	0.000348	0.000769	CcSEcCtD
Asenapine—Angioedema—Prednisolone—psoriasis	0.000348	0.000768	CcSEcCtD
Asenapine—Arthralgia—Mycophenolate mofetil—psoriasis	0.000347	0.000767	CcSEcCtD
Asenapine—Breast disorder—Methotrexate—psoriasis	0.000347	0.000766	CcSEcCtD
Asenapine—Anxiety—Mycophenolate mofetil—psoriasis	0.000346	0.000764	CcSEcCtD
Asenapine—Malaise—Prednisolone—psoriasis	0.000343	0.000758	CcSEcCtD
Asenapine—Dysgeusia—Triamcinolone—psoriasis	0.000343	0.000757	CcSEcCtD
Asenapine—Anaphylactic shock—Cyclosporine—psoriasis	0.000341	0.000754	CcSEcCtD
Asenapine—Syncope—Prednisolone—psoriasis	0.000341	0.000754	CcSEcCtD
Asenapine—Eye disorder—Betamethasone—psoriasis	0.000341	0.000753	CcSEcCtD
Asenapine—Eye disorder—Dexamethasone—psoriasis	0.000341	0.000753	CcSEcCtD
Asenapine—Dry mouth—Mycophenolate mofetil—psoriasis	0.00034	0.00075	CcSEcCtD
Asenapine—Angioedema—Hydrocortisone—psoriasis	0.000339	0.00075	CcSEcCtD
Asenapine—Malaise—Hydrocortisone—psoriasis	0.000335	0.00074	CcSEcCtD
Asenapine—Nervous system disorder—Cyclosporine—psoriasis	0.000335	0.000739	CcSEcCtD
Asenapine—Loss of consciousness—Prednisolone—psoriasis	0.000334	0.000739	CcSEcCtD
Asenapine—Thrombocytopenia—Cyclosporine—psoriasis	0.000334	0.000738	CcSEcCtD
Asenapine—Syncope—Hydrocortisone—psoriasis	0.000333	0.000736	CcSEcCtD
Asenapine—Dizziness—Hydroxyurea—psoriasis	0.000333	0.000735	CcSEcCtD
Asenapine—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000333	0.000735	CcSEcCtD
Asenapine—Angiopathy—Dexamethasone—psoriasis	0.000331	0.000731	CcSEcCtD
Asenapine—Angiopathy—Betamethasone—psoriasis	0.000331	0.000731	CcSEcCtD
Asenapine—Convulsion—Prednisolone—psoriasis	0.00033	0.000728	CcSEcCtD
Asenapine—Hypertension—Prednisolone—psoriasis	0.000328	0.000725	CcSEcCtD
Asenapine—Shock—Mycophenolate mofetil—psoriasis	0.000327	0.000723	CcSEcCtD
Asenapine—Loss of consciousness—Hydrocortisone—psoriasis	0.000326	0.000721	CcSEcCtD
Asenapine—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000326	0.000721	CcSEcCtD
Asenapine—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000326	0.00072	CcSEcCtD
Asenapine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000325	0.000717	CcSEcCtD
Asenapine—Convulsion—Hydrocortisone—psoriasis	0.000322	0.000711	CcSEcCtD
Asenapine—Hypertension—Hydrocortisone—psoriasis	0.000321	0.000709	CcSEcCtD
Asenapine—Vomiting—Hydroxyurea—psoriasis	0.00032	0.000707	CcSEcCtD
Asenapine—Angioedema—Triamcinolone—psoriasis	0.00032	0.000706	CcSEcCtD
Asenapine—Abdominal discomfort—Methotrexate—psoriasis	0.000318	0.000702	CcSEcCtD
Asenapine—Rash—Hydroxyurea—psoriasis	0.000317	0.000701	CcSEcCtD
Asenapine—Dermatitis—Hydroxyurea—psoriasis	0.000317	0.000701	CcSEcCtD
Asenapine—Malaise—Triamcinolone—psoriasis	0.000315	0.000697	CcSEcCtD
Asenapine—Headache—Hydroxyurea—psoriasis	0.000315	0.000697	CcSEcCtD
Asenapine—Anxiety—Hydrocortisone—psoriasis	0.000315	0.000696	CcSEcCtD
Asenapine—Syncope—Triamcinolone—psoriasis	0.000314	0.000693	CcSEcCtD
Asenapine—Connective tissue disorder—Prednisone—psoriasis	0.000312	0.000689	CcSEcCtD
Asenapine—Hypotension—Mycophenolate mofetil—psoriasis	0.000311	0.000687	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000311	0.000687	CcSEcCtD
Asenapine—Anaphylactic shock—Prednisolone—psoriasis	0.00031	0.000686	CcSEcCtD
Asenapine—Neutropenia—Methotrexate—psoriasis	0.00031	0.000685	CcSEcCtD
Asenapine—Insomnia—Cyclosporine—psoriasis	0.000309	0.000682	CcSEcCtD
Asenapine—Loss of consciousness—Triamcinolone—psoriasis	0.000307	0.000679	CcSEcCtD
Asenapine—Shock—Prednisolone—psoriasis	0.000305	0.000675	CcSEcCtD
Asenapine—Dyspnoea—Cyclosporine—psoriasis	0.000304	0.000672	CcSEcCtD
Asenapine—Somnolence—Cyclosporine—psoriasis	0.000303	0.00067	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000303	0.00067	CcSEcCtD
Asenapine—Anaphylactic shock—Hydrocortisone—psoriasis	0.000303	0.00067	CcSEcCtD
Asenapine—Convulsion—Triamcinolone—psoriasis	0.000303	0.00067	CcSEcCtD
Asenapine—Tachycardia—Prednisolone—psoriasis	0.000303	0.000669	CcSEcCtD
Asenapine—Asthenia—Mycophenolic acid—psoriasis	0.000303	0.000668	CcSEcCtD
Asenapine—Hypertension—Triamcinolone—psoriasis	0.000302	0.000667	CcSEcCtD
Asenapine—Insomnia—Mycophenolate mofetil—psoriasis	0.000301	0.000665	CcSEcCtD
Asenapine—Dyspepsia—Cyclosporine—psoriasis	0.0003	0.000663	CcSEcCtD
Asenapine—Nausea—Hydroxyurea—psoriasis	0.000299	0.000661	CcSEcCtD
Asenapine—Shock—Hydrocortisone—psoriasis	0.000298	0.000659	CcSEcCtD
Asenapine—Nervous system disorder—Hydrocortisone—psoriasis	0.000297	0.000657	CcSEcCtD
Asenapine—Eye disorder—Prednisone—psoriasis	0.000297	0.000655	CcSEcCtD
Asenapine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000297	0.000655	CcSEcCtD
Asenapine—Tachycardia—Hydrocortisone—psoriasis	0.000296	0.000654	CcSEcCtD
Asenapine—Somnolence—Mycophenolate mofetil—psoriasis	0.000296	0.000654	CcSEcCtD
Asenapine—Depression—Methotrexate—psoriasis	0.000295	0.000651	CcSEcCtD
Asenapine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000295	0.000651	CcSEcCtD
Asenapine—Fatigue—Cyclosporine—psoriasis	0.000294	0.00065	CcSEcCtD
Asenapine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000293	0.000647	CcSEcCtD
Asenapine—Constipation—Cyclosporine—psoriasis	0.000292	0.000644	CcSEcCtD
Asenapine—Dry mouth—Triamcinolone—psoriasis	0.000291	0.000643	CcSEcCtD
Asenapine—Angioedema—Dexamethasone—psoriasis	0.00029	0.000641	CcSEcCtD
Asenapine—Angioedema—Betamethasone—psoriasis	0.00029	0.000641	CcSEcCtD
Asenapine—Stomatitis—Methotrexate—psoriasis	0.000288	0.000636	CcSEcCtD
Asenapine—Angiopathy—Prednisone—psoriasis	0.000288	0.000636	CcSEcCtD
Asenapine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000287	0.000635	CcSEcCtD
Asenapine—Immune system disorder—Prednisone—psoriasis	0.000287	0.000634	CcSEcCtD
Asenapine—Malaise—Dexamethasone—psoriasis	0.000286	0.000632	CcSEcCtD
Asenapine—Malaise—Betamethasone—psoriasis	0.000286	0.000632	CcSEcCtD
Asenapine—Anaphylactic shock—Triamcinolone—psoriasis	0.000285	0.000631	CcSEcCtD
Asenapine—Syncope—Dexamethasone—psoriasis	0.000285	0.000629	CcSEcCtD
Asenapine—Syncope—Betamethasone—psoriasis	0.000285	0.000629	CcSEcCtD
Asenapine—Constipation—Mycophenolate mofetil—psoriasis	0.000285	0.000629	CcSEcCtD
Asenapine—Hypotension—Hydrocortisone—psoriasis	0.000283	0.000626	CcSEcCtD
Asenapine—Shock—Triamcinolone—psoriasis	0.000281	0.00062	CcSEcCtD
Asenapine—Insomnia—Prednisolone—psoriasis	0.000281	0.00062	CcSEcCtD
Asenapine—Hepatobiliary disease—Methotrexate—psoriasis	0.00028	0.000618	CcSEcCtD
Asenapine—Loss of consciousness—Betamethasone—psoriasis	0.000279	0.000616	CcSEcCtD
Asenapine—Loss of consciousness—Dexamethasone—psoriasis	0.000279	0.000616	CcSEcCtD
Asenapine—Dizziness—Mycophenolic acid—psoriasis	0.000279	0.000616	CcSEcCtD
Asenapine—Tachycardia—Triamcinolone—psoriasis	0.000279	0.000615	CcSEcCtD
Asenapine—Mental disorder—Prednisone—psoriasis	0.000278	0.000615	CcSEcCtD
Asenapine—Malnutrition—Prednisone—psoriasis	0.000276	0.000611	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000276	0.00061	CcSEcCtD
Asenapine—Agranulocytosis—Methotrexate—psoriasis	0.000276	0.000609	CcSEcCtD
Asenapine—Convulsion—Dexamethasone—psoriasis	0.000275	0.000607	CcSEcCtD
Asenapine—Convulsion—Betamethasone—psoriasis	0.000275	0.000607	CcSEcCtD
Asenapine—Insomnia—Hydrocortisone—psoriasis	0.000274	0.000606	CcSEcCtD
Asenapine—Hypertension—Betamethasone—psoriasis	0.000274	0.000605	CcSEcCtD
Asenapine—Hypertension—Dexamethasone—psoriasis	0.000274	0.000605	CcSEcCtD
Asenapine—Anxiety—Dexamethasone—psoriasis	0.000269	0.000595	CcSEcCtD
Asenapine—Anxiety—Betamethasone—psoriasis	0.000269	0.000595	CcSEcCtD
Asenapine—Vomiting—Mycophenolic acid—psoriasis	0.000268	0.000592	CcSEcCtD
Asenapine—Dyspepsia—Hydrocortisone—psoriasis	0.000267	0.00059	CcSEcCtD
Asenapine—Rash—Mycophenolic acid—psoriasis	0.000266	0.000587	CcSEcCtD
Asenapine—Dermatitis—Mycophenolic acid—psoriasis	0.000266	0.000587	CcSEcCtD
Asenapine—Headache—Mycophenolic acid—psoriasis	0.000264	0.000584	CcSEcCtD
Asenapine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000262	0.000578	CcSEcCtD
Asenapine—Fatigue—Hydrocortisone—psoriasis	0.000261	0.000577	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.00026	0.000575	CcSEcCtD
Asenapine—Anaphylactic shock—Dexamethasone—psoriasis	0.000259	0.000572	CcSEcCtD
Asenapine—Anaphylactic shock—Betamethasone—psoriasis	0.000259	0.000572	CcSEcCtD
Asenapine—Insomnia—Triamcinolone—psoriasis	0.000258	0.00057	CcSEcCtD
Asenapine—Anaemia—Prednisone—psoriasis	0.000255	0.000564	CcSEcCtD
Asenapine—Shock—Betamethasone—psoriasis	0.000255	0.000563	CcSEcCtD
Asenapine—Shock—Dexamethasone—psoriasis	0.000255	0.000563	CcSEcCtD
Asenapine—Dyspnoea—Triamcinolone—psoriasis	0.000255	0.000562	CcSEcCtD
Asenapine—Nervous system disorder—Dexamethasone—psoriasis	0.000254	0.000561	CcSEcCtD
Asenapine—Nervous system disorder—Betamethasone—psoriasis	0.000254	0.000561	CcSEcCtD
Asenapine—Agitation—Prednisone—psoriasis	0.000254	0.000561	CcSEcCtD
Asenapine—Thrombocytopenia—Dexamethasone—psoriasis	0.000254	0.00056	CcSEcCtD
Asenapine—Thrombocytopenia—Betamethasone—psoriasis	0.000254	0.00056	CcSEcCtD
Asenapine—Tachycardia—Betamethasone—psoriasis	0.000253	0.000558	CcSEcCtD
Asenapine—Tachycardia—Dexamethasone—psoriasis	0.000253	0.000558	CcSEcCtD
Asenapine—Angioedema—Prednisone—psoriasis	0.000253	0.000558	CcSEcCtD
Asenapine—Hypersensitivity—Cyclosporine—psoriasis	0.000251	0.000555	CcSEcCtD
Asenapine—Dyspepsia—Triamcinolone—psoriasis	0.000251	0.000555	CcSEcCtD
Asenapine—Nausea—Mycophenolic acid—psoriasis	0.00025	0.000553	CcSEcCtD
Asenapine—Malaise—Prednisone—psoriasis	0.000249	0.000551	CcSEcCtD
Asenapine—Eye disorder—Methotrexate—psoriasis	0.000248	0.000548	CcSEcCtD
Asenapine—Syncope—Prednisone—psoriasis	0.000248	0.000548	CcSEcCtD
Asenapine—Cardiac disorder—Methotrexate—psoriasis	0.000246	0.000544	CcSEcCtD
Asenapine—Fatigue—Triamcinolone—psoriasis	0.000246	0.000544	CcSEcCtD
Asenapine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000245	0.000542	CcSEcCtD
Asenapine—Asthenia—Cyclosporine—psoriasis	0.000245	0.000541	CcSEcCtD
Asenapine—Loss of consciousness—Prednisone—psoriasis	0.000243	0.000537	CcSEcCtD
Asenapine—Hypotension—Dexamethasone—psoriasis	0.000242	0.000535	CcSEcCtD
Asenapine—Hypotension—Betamethasone—psoriasis	0.000242	0.000535	CcSEcCtD
Asenapine—Angiopathy—Methotrexate—psoriasis	0.000241	0.000532	CcSEcCtD
Asenapine—Immune system disorder—Methotrexate—psoriasis	0.00024	0.000529	CcSEcCtD
Asenapine—Convulsion—Prednisone—psoriasis	0.000239	0.000529	CcSEcCtD
Asenapine—Mediastinal disorder—Methotrexate—psoriasis	0.000239	0.000528	CcSEcCtD
Asenapine—Asthenia—Mycophenolate mofetil—psoriasis	0.000239	0.000527	CcSEcCtD
Asenapine—Hypertension—Prednisone—psoriasis	0.000239	0.000527	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000236	0.000521	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000236	0.000521	CcSEcCtD
Asenapine—Arthralgia—Prednisone—psoriasis	0.000235	0.00052	CcSEcCtD
Asenapine—Anxiety—Prednisone—psoriasis	0.000234	0.000518	CcSEcCtD
Asenapine—Insomnia—Betamethasone—psoriasis	0.000234	0.000518	CcSEcCtD
Asenapine—Insomnia—Dexamethasone—psoriasis	0.000234	0.000518	CcSEcCtD
Asenapine—Mental disorder—Methotrexate—psoriasis	0.000232	0.000514	CcSEcCtD
Asenapine—Malnutrition—Methotrexate—psoriasis	0.000231	0.00051	CcSEcCtD
Asenapine—Hypersensitivity—Prednisolone—psoriasis	0.000229	0.000505	CcSEcCtD
Asenapine—Dyspepsia—Dexamethasone—psoriasis	0.000228	0.000504	CcSEcCtD
Asenapine—Dyspepsia—Betamethasone—psoriasis	0.000228	0.000504	CcSEcCtD
Asenapine—Dysgeusia—Methotrexate—psoriasis	0.000226	0.0005	CcSEcCtD
Asenapine—Dizziness—Cyclosporine—psoriasis	0.000226	0.000498	CcSEcCtD
Asenapine—Anaphylactic shock—Prednisone—psoriasis	0.000226	0.000498	CcSEcCtD
Asenapine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000224	0.000494	CcSEcCtD
Asenapine—Gastrointestinal disorder—Betamethasone—psoriasis	0.000224	0.000494	CcSEcCtD
Asenapine—Hypersensitivity—Hydrocortisone—psoriasis	0.000223	0.000493	CcSEcCtD
Asenapine—Fatigue—Dexamethasone—psoriasis	0.000223	0.000493	CcSEcCtD
Asenapine—Fatigue—Betamethasone—psoriasis	0.000223	0.000493	CcSEcCtD
Asenapine—Shock—Prednisone—psoriasis	0.000222	0.00049	CcSEcCtD
Asenapine—Nervous system disorder—Prednisone—psoriasis	0.000221	0.000489	CcSEcCtD
Asenapine—Tachycardia—Prednisone—psoriasis	0.00022	0.000486	CcSEcCtD
Asenapine—Dizziness—Mycophenolate mofetil—psoriasis	0.00022	0.000486	CcSEcCtD
Asenapine—Asthenia—Hydrocortisone—psoriasis	0.000218	0.000481	CcSEcCtD
Asenapine—Vomiting—Cyclosporine—psoriasis	0.000217	0.000479	CcSEcCtD
Asenapine—Rash—Cyclosporine—psoriasis	0.000215	0.000475	CcSEcCtD
Asenapine—Dermatitis—Cyclosporine—psoriasis	0.000215	0.000475	CcSEcCtD
Asenapine—Headache—Cyclosporine—psoriasis	0.000214	0.000472	CcSEcCtD
Asenapine—Anaemia—Methotrexate—psoriasis	0.000213	0.000472	CcSEcCtD
Asenapine—Vomiting—Mycophenolate mofetil—psoriasis	0.000212	0.000467	CcSEcCtD
Asenapine—Hypersensitivity—Triamcinolone—psoriasis	0.00021	0.000465	CcSEcCtD
Asenapine—Rash—Mycophenolate mofetil—psoriasis	0.00021	0.000464	CcSEcCtD
Asenapine—Dermatitis—Mycophenolate mofetil—psoriasis	0.00021	0.000463	CcSEcCtD
Asenapine—Headache—Mycophenolate mofetil—psoriasis	0.000208	0.000461	CcSEcCtD
Asenapine—Malaise—Methotrexate—psoriasis	0.000208	0.00046	CcSEcCtD
Asenapine—Leukopenia—Methotrexate—psoriasis	0.000207	0.000457	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000206	0.000454	CcSEcCtD
Asenapine—Dizziness—Prednisolone—psoriasis	0.000205	0.000453	CcSEcCtD
Asenapine—Asthenia—Triamcinolone—psoriasis	0.000205	0.000452	CcSEcCtD
Asenapine—Insomnia—Prednisone—psoriasis	0.000204	0.000451	CcSEcCtD
Asenapine—Nausea—Cyclosporine—psoriasis	0.000203	0.000448	CcSEcCtD
Asenapine—Dizziness—Hydrocortisone—psoriasis	0.0002	0.000443	CcSEcCtD
Asenapine—Convulsion—Methotrexate—psoriasis	0.0002	0.000442	CcSEcCtD
Asenapine—Dyspepsia—Prednisone—psoriasis	0.000199	0.000439	CcSEcCtD
Asenapine—Nausea—Mycophenolate mofetil—psoriasis	0.000198	0.000437	CcSEcCtD
Asenapine—Arthralgia—Methotrexate—psoriasis	0.000197	0.000434	CcSEcCtD
Asenapine—Rash—Prednisolone—psoriasis	0.000196	0.000432	CcSEcCtD
Asenapine—Dermatitis—Prednisolone—psoriasis	0.000196	0.000432	CcSEcCtD
Asenapine—Fatigue—Prednisone—psoriasis	0.000194	0.00043	CcSEcCtD
Asenapine—Headache—Prednisolone—psoriasis	0.000194	0.00043	CcSEcCtD
Asenapine—Constipation—Prednisone—psoriasis	0.000193	0.000426	CcSEcCtD
Asenapine—Vomiting—Hydrocortisone—psoriasis	0.000193	0.000426	CcSEcCtD
Asenapine—Rash—Hydrocortisone—psoriasis	0.000191	0.000422	CcSEcCtD
Asenapine—Dermatitis—Hydrocortisone—psoriasis	0.000191	0.000422	CcSEcCtD
Asenapine—Headache—Hydrocortisone—psoriasis	0.00019	0.00042	CcSEcCtD
Asenapine—Dizziness—Triamcinolone—psoriasis	0.000189	0.000417	CcSEcCtD
Asenapine—Anaphylactic shock—Methotrexate—psoriasis	0.000189	0.000416	CcSEcCtD
Asenapine—Asthenia—Betamethasone—psoriasis	0.000186	0.000411	CcSEcCtD
Asenapine—Asthenia—Dexamethasone—psoriasis	0.000186	0.000411	CcSEcCtD
Asenapine—Nervous system disorder—Methotrexate—psoriasis	0.000185	0.000408	CcSEcCtD
Asenapine—Thrombocytopenia—Methotrexate—psoriasis	0.000185	0.000408	CcSEcCtD
Asenapine—Nausea—Prednisolone—psoriasis	0.000184	0.000407	CcSEcCtD
Asenapine—Vomiting—Triamcinolone—psoriasis	0.000182	0.000401	CcSEcCtD
Asenapine—Nausea—Hydrocortisone—psoriasis	0.00018	0.000398	CcSEcCtD
Asenapine—Rash—Triamcinolone—psoriasis	0.00018	0.000398	CcSEcCtD
Asenapine—Dermatitis—Triamcinolone—psoriasis	0.00018	0.000397	CcSEcCtD
Asenapine—Headache—Triamcinolone—psoriasis	0.000179	0.000395	CcSEcCtD
Asenapine—Hypotension—Methotrexate—psoriasis	0.000176	0.000389	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000172	0.000379	CcSEcCtD
Asenapine—Dizziness—Betamethasone—psoriasis	0.000171	0.000378	CcSEcCtD
Asenapine—Dizziness—Dexamethasone—psoriasis	0.000171	0.000378	CcSEcCtD
Asenapine—Insomnia—Methotrexate—psoriasis	0.000171	0.000377	CcSEcCtD
Asenapine—Nausea—Triamcinolone—psoriasis	0.00017	0.000375	CcSEcCtD
Asenapine—Dyspnoea—Methotrexate—psoriasis	0.000168	0.000371	CcSEcCtD
Asenapine—Somnolence—Methotrexate—psoriasis	0.000168	0.00037	CcSEcCtD
Asenapine—Hypersensitivity—Prednisone—psoriasis	0.000166	0.000367	CcSEcCtD
Asenapine—Dyspepsia—Methotrexate—psoriasis	0.000166	0.000367	CcSEcCtD
Asenapine—Vomiting—Betamethasone—psoriasis	0.000165	0.000364	CcSEcCtD
Asenapine—Vomiting—Dexamethasone—psoriasis	0.000165	0.000364	CcSEcCtD
Asenapine—Rash—Dexamethasone—psoriasis	0.000163	0.000361	CcSEcCtD
Asenapine—Rash—Betamethasone—psoriasis	0.000163	0.000361	CcSEcCtD
Asenapine—Dermatitis—Dexamethasone—psoriasis	0.000163	0.00036	CcSEcCtD
Asenapine—Dermatitis—Betamethasone—psoriasis	0.000163	0.00036	CcSEcCtD
Asenapine—Gastrointestinal disorder—Methotrexate—psoriasis	0.000163	0.00036	CcSEcCtD
Asenapine—Fatigue—Methotrexate—psoriasis	0.000163	0.000359	CcSEcCtD
Asenapine—Headache—Betamethasone—psoriasis	0.000162	0.000358	CcSEcCtD
Asenapine—Headache—Dexamethasone—psoriasis	0.000162	0.000358	CcSEcCtD
Asenapine—Asthenia—Prednisone—psoriasis	0.000162	0.000358	CcSEcCtD
Asenapine—Nausea—Dexamethasone—psoriasis	0.000154	0.00034	CcSEcCtD
Asenapine—Nausea—Betamethasone—psoriasis	0.000154	0.00034	CcSEcCtD
Asenapine—Dizziness—Prednisone—psoriasis	0.000149	0.00033	CcSEcCtD
Asenapine—Vomiting—Prednisone—psoriasis	0.000143	0.000317	CcSEcCtD
Asenapine—Rash—Prednisone—psoriasis	0.000142	0.000314	CcSEcCtD
Asenapine—Dermatitis—Prednisone—psoriasis	0.000142	0.000314	CcSEcCtD
Asenapine—Headache—Prednisone—psoriasis	0.000141	0.000312	CcSEcCtD
Asenapine—Hypersensitivity—Methotrexate—psoriasis	0.000139	0.000307	CcSEcCtD
Asenapine—Asthenia—Methotrexate—psoriasis	0.000135	0.000299	CcSEcCtD
Asenapine—Nausea—Prednisone—psoriasis	0.000134	0.000296	CcSEcCtD
Asenapine—Dizziness—Methotrexate—psoriasis	0.000125	0.000275	CcSEcCtD
Asenapine—Vomiting—Methotrexate—psoriasis	0.00012	0.000265	CcSEcCtD
Asenapine—Rash—Methotrexate—psoriasis	0.000119	0.000263	CcSEcCtD
Asenapine—Dermatitis—Methotrexate—psoriasis	0.000119	0.000262	CcSEcCtD
Asenapine—Headache—Methotrexate—psoriasis	0.000118	0.000261	CcSEcCtD
Asenapine—Nausea—Methotrexate—psoriasis	0.000112	0.000247	CcSEcCtD
Asenapine—HTR2C—Signaling by GPCR—CXCL8—psoriasis	1.74e-05	0.000186	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—TYK2—psoriasis	1.74e-05	0.000186	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—TYK2—psoriasis	1.73e-05	0.000185	CbGpPWpGaD
Asenapine—HRH2—Signaling by GPCR—IL6—psoriasis	1.73e-05	0.000185	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—TYK2—psoriasis	1.7e-05	0.000182	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—CXCL8—psoriasis	1.69e-05	0.000181	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—JUN—psoriasis	1.69e-05	0.000181	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	1.69e-05	0.000181	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CARM1—psoriasis	1.69e-05	0.000181	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—NFKBIA—psoriasis	1.68e-05	0.00018	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	1.66e-05	0.000178	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—NFKBIA—psoriasis	1.66e-05	0.000178	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—CXCL8—psoriasis	1.66e-05	0.000178	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—VEGFA—psoriasis	1.66e-05	0.000178	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—SOCS1—psoriasis	1.66e-05	0.000177	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—STAT3—psoriasis	1.64e-05	0.000176	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	1.63e-05	0.000174	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—NFKB1—psoriasis	1.63e-05	0.000174	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—APOE—psoriasis	1.63e-05	0.000174	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—LEP—psoriasis	1.63e-05	0.000174	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—APOE—psoriasis	1.61e-05	0.000172	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—LEP—psoriasis	1.61e-05	0.000172	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TYK2—psoriasis	1.6e-05	0.000172	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TYK2—psoriasis	1.6e-05	0.000171	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TYK2—psoriasis	1.59e-05	0.00017	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—LEP—psoriasis	1.59e-05	0.00017	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—APOE—psoriasis	1.59e-05	0.00017	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—TYK2—psoriasis	1.58e-05	0.000169	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.58e-05	0.000169	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—PPARG—psoriasis	1.57e-05	0.000168	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TYK2—psoriasis	1.56e-05	0.000167	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—APOE—psoriasis	1.55e-05	0.000166	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—LEP—psoriasis	1.55e-05	0.000166	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—LEP—psoriasis	1.55e-05	0.000166	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—APOE—psoriasis	1.55e-05	0.000166	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—CXCL8—psoriasis	1.54e-05	0.000164	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TYK2—psoriasis	1.53e-05	0.000164	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—NFKBIA—psoriasis	1.51e-05	0.000162	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	1.51e-05	0.000162	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	1.51e-05	0.000162	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—CXCL8—psoriasis	1.51e-05	0.000161	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—APOE—psoriasis	1.5e-05	0.000161	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—LEP—psoriasis	1.5e-05	0.000161	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	1.5e-05	0.000161	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—NFKBIA—psoriasis	1.48e-05	0.000159	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	1.48e-05	0.000158	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—VEGFA—psoriasis	1.48e-05	0.000158	CbGpPWpGaD
Asenapine—ADRA2A—Hemostasis—TP53—psoriasis	1.47e-05	0.000157	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—STAT3—psoriasis	1.46e-05	0.000157	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TYK2—psoriasis	1.46e-05	0.000157	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—APOE—psoriasis	1.46e-05	0.000156	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	1.45e-05	0.000155	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	1.44e-05	0.000154	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—NFKBIA—psoriasis	1.4e-05	0.00015	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—CXCL8—psoriasis	1.4e-05	0.000149	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—CXCL8—psoriasis	1.39e-05	0.000149	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—CXCL8—psoriasis	1.38e-05	0.000148	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TYK2—psoriasis	1.38e-05	0.000148	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	1.37e-05	0.000147	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—LEP—psoriasis	1.36e-05	0.000146	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—APOE—psoriasis	1.36e-05	0.000146	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TYK2—psoriasis	1.36e-05	0.000146	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—CXCL8—psoriasis	1.36e-05	0.000145	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—LEP—psoriasis	1.34e-05	0.000144	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—APOE—psoriasis	1.34e-05	0.000144	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—LEP—psoriasis	1.34e-05	0.000143	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—APOE—psoriasis	1.34e-05	0.000143	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—CXCL8—psoriasis	1.33e-05	0.000143	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—IL6—psoriasis	1.33e-05	0.000142	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—IL6—psoriasis	1.33e-05	0.000142	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—IL6—psoriasis	1.32e-05	0.000141	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—LEP—psoriasis	1.31e-05	0.000141	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—APOE—psoriasis	1.31e-05	0.000141	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CARM1—psoriasis	1.3e-05	0.000139	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—JUN—psoriasis	1.3e-05	0.000139	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—JUN—psoriasis	1.3e-05	0.000139	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—IL6—psoriasis	1.29e-05	0.000138	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—JUN—psoriasis	1.29e-05	0.000138	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CXCL8—psoriasis	1.27e-05	0.000136	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PPARG—psoriasis	1.27e-05	0.000136	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—NFKBIA—psoriasis	1.27e-05	0.000136	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—IL6—psoriasis	1.27e-05	0.000136	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—JUN—psoriasis	1.26e-05	0.000135	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—TP53—psoriasis	1.25e-05	0.000134	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	1.25e-05	0.000134	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—NFKB1—psoriasis	1.25e-05	0.000134	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—NFKBIA—psoriasis	1.25e-05	0.000134	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—NFKB1—psoriasis	1.25e-05	0.000134	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—JUN—psoriasis	1.24e-05	0.000133	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TYK2—psoriasis	1.24e-05	0.000133	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—NFKB1—psoriasis	1.24e-05	0.000133	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TYK2—psoriasis	1.23e-05	0.000132	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CAT—psoriasis	1.23e-05	0.000131	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	1.23e-05	0.000131	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—LEP—psoriasis	1.22e-05	0.000131	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—APOE—psoriasis	1.22e-05	0.000131	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—NFKB1—psoriasis	1.21e-05	0.00013	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TYK2—psoriasis	1.21e-05	0.00013	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—IL6—psoriasis	1.21e-05	0.00013	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CXCL8—psoriasis	1.2e-05	0.000129	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—NFKB1—psoriasis	1.19e-05	0.000128	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TYK2—psoriasis	1.19e-05	0.000127	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CXCL8—psoriasis	1.19e-05	0.000127	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—JUN—psoriasis	1.18e-05	0.000127	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TYK2—psoriasis	1.18e-05	0.000126	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TYK2—psoriasis	1.15e-05	0.000123	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—IL6—psoriasis	1.15e-05	0.000123	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—IL6—psoriasis	1.14e-05	0.000122	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—NFKB1—psoriasis	1.14e-05	0.000122	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	1.14e-05	0.000122	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—VEGFA—psoriasis	1.13e-05	0.000121	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—VEGFA—psoriasis	1.13e-05	0.000121	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—IL6—psoriasis	1.13e-05	0.000121	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—VEGFA—psoriasis	1.12e-05	0.00012	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—STAT3—psoriasis	1.12e-05	0.00012	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—STAT3—psoriasis	1.12e-05	0.00012	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—JUN—psoriasis	1.12e-05	0.00012	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—TP53—psoriasis	1.12e-05	0.00012	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—STAT3—psoriasis	1.11e-05	0.000119	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—JUN—psoriasis	1.1e-05	0.000118	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—VEGFA—psoriasis	1.1e-05	0.000118	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—STAT3—psoriasis	1.09e-05	0.000117	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—VEGFA—psoriasis	1.08e-05	0.000116	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CXCL8—psoriasis	1.08e-05	0.000116	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—NFKB1—psoriasis	1.08e-05	0.000115	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—STAT3—psoriasis	1.07e-05	0.000115	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CXCL8—psoriasis	1.07e-05	0.000115	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—NFKB1—psoriasis	1.06e-05	0.000114	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CXCL8—psoriasis	1.06e-05	0.000113	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TYK2—psoriasis	1.04e-05	0.000112	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CAT—psoriasis	1.04e-05	0.000111	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—VEGFA—psoriasis	1.03e-05	0.000111	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CXCL8—psoriasis	1.03e-05	0.000111	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CXCL8—psoriasis	1.03e-05	0.00011	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—IL6—psoriasis	1.03e-05	0.00011	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TYK2—psoriasis	1.02e-05	0.00011	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—STAT3—psoriasis	1.02e-05	0.00011	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TYK2—psoriasis	1.02e-05	0.000109	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—IL6—psoriasis	1.02e-05	0.000109	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—IL6—psoriasis	1.02e-05	0.000109	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—IL6—psoriasis	1e-05	0.000108	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—JUN—psoriasis	1e-05	0.000107	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TYK2—psoriasis	1e-05	0.000107	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CXCL8—psoriasis	1e-05	0.000107	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—JUN—psoriasis	9.95e-06	0.000106	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—IL6—psoriasis	9.82e-06	0.000105	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—JUN—psoriasis	9.82e-06	0.000105	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—IL6—psoriasis	9.77e-06	0.000105	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—VEGFA—psoriasis	9.76e-06	0.000104	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—NFKB1—psoriasis	9.66e-06	0.000103	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—STAT3—psoriasis	9.66e-06	0.000103	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—VEGFA—psoriasis	9.63e-06	0.000103	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—JUN—psoriasis	9.6e-06	0.000103	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—NFKB1—psoriasis	9.58e-06	0.000103	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—JUN—psoriasis	9.55e-06	0.000102	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—STAT3—psoriasis	9.53e-06	0.000102	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOE—psoriasis	9.52e-06	0.000102	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—IL6—psoriasis	9.51e-06	0.000102	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—NFKB1—psoriasis	9.45e-06	0.000101	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TYK2—psoriasis	9.33e-06	9.98e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—JUN—psoriasis	9.29e-06	9.95e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—NFKB1—psoriasis	9.24e-06	9.9e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—NFKB1—psoriasis	9.2e-06	9.84e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CXCL8—psoriasis	9.07e-06	9.71e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—NFKB1—psoriasis	8.95e-06	9.57e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CXCL8—psoriasis	8.92e-06	9.55e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CXCL8—psoriasis	8.91e-06	9.53e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—VEGFA—psoriasis	8.77e-06	9.39e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CXCL8—psoriasis	8.74e-06	9.35e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—VEGFA—psoriasis	8.69e-06	9.3e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—STAT3—psoriasis	8.69e-06	9.3e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL6—psoriasis	8.62e-06	9.23e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—STAT3—psoriasis	8.61e-06	9.21e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—VEGFA—psoriasis	8.58e-06	9.18e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TP53—psoriasis	8.56e-06	9.17e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TP53—psoriasis	8.55e-06	9.16e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TP53—psoriasis	8.5e-06	9.1e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—STAT3—psoriasis	8.5e-06	9.09e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL6—psoriasis	8.49e-06	9.08e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL6—psoriasis	8.47e-06	9.06e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—JUN—psoriasis	8.43e-06	9.03e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—VEGFA—psoriasis	8.39e-06	8.98e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—VEGFA—psoriasis	8.35e-06	8.93e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TP53—psoriasis	8.32e-06	8.91e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL6—psoriasis	8.31e-06	8.89e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—STAT3—psoriasis	8.31e-06	8.89e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—JUN—psoriasis	8.3e-06	8.88e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PPARG—psoriasis	8.29e-06	8.88e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—JUN—psoriasis	8.28e-06	8.86e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—STAT3—psoriasis	8.26e-06	8.85e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TP53—psoriasis	8.19e-06	8.77e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—JUN—psoriasis	8.12e-06	8.7e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	8.12e-06	8.69e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—VEGFA—psoriasis	8.12e-06	8.69e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—NFKB1—psoriasis	8.12e-06	8.69e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOE—psoriasis	8.07e-06	8.63e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—STAT3—psoriasis	8.04e-06	8.6e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CAT—psoriasis	8.01e-06	8.58e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—NFKB1—psoriasis	7.99e-06	8.55e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—NFKB1—psoriasis	7.97e-06	8.53e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL6—psoriasis	7.84e-06	8.39e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL6—psoriasis	7.83e-06	8.38e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NFKB1—psoriasis	7.82e-06	8.37e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TP53—psoriasis	7.82e-06	8.37e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL6—psoriasis	7.78e-06	8.33e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL6—psoriasis	7.72e-06	8.26e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL6—psoriasis	7.62e-06	8.15e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—JUN—psoriasis	7.55e-06	8.08e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL6—psoriasis	7.5e-06	8.02e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TP53—psoriasis	7.37e-06	7.89e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—VEGFA—psoriasis	7.37e-06	7.88e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—STAT3—psoriasis	7.29e-06	7.81e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TP53—psoriasis	7.27e-06	7.79e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	7.27e-06	7.78e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—VEGFA—psoriasis	7.25e-06	7.76e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—VEGFA—psoriasis	7.23e-06	7.74e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—STAT3—psoriasis	7.18e-06	7.68e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—STAT3—psoriasis	7.16e-06	7.67e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL6—psoriasis	7.16e-06	7.66e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—VEGFA—psoriasis	7.1e-06	7.6e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—STAT3—psoriasis	7.03e-06	7.52e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PPARG—psoriasis	7.03e-06	7.52e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL6—psoriasis	6.75e-06	7.22e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL6—psoriasis	6.66e-06	7.13e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TP53—psoriasis	6.63e-06	7.09e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	6.59e-06	7.06e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TP53—psoriasis	6.57e-06	7.03e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—STAT3—psoriasis	6.53e-06	6.99e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TP53—psoriasis	6.48e-06	6.94e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TP53—psoriasis	6.34e-06	6.79e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TP53—psoriasis	6.31e-06	6.75e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOE—psoriasis	6.23e-06	6.66e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TP53—psoriasis	6.13e-06	6.57e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL6—psoriasis	6.07e-06	6.49e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL6—psoriasis	6.01e-06	6.43e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL6—psoriasis	5.93e-06	6.35e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL6—psoriasis	5.8e-06	6.21e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL6—psoriasis	5.77e-06	6.18e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL6—psoriasis	5.62e-06	6.01e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TP53—psoriasis	5.57e-06	5.96e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TP53—psoriasis	5.48e-06	5.86e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TP53—psoriasis	5.47e-06	5.85e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPARG—psoriasis	5.42e-06	5.8e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TP53—psoriasis	5.36e-06	5.74e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL6—psoriasis	5.09e-06	5.45e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL6—psoriasis	5.01e-06	5.37e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL6—psoriasis	5e-06	5.35e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TP53—psoriasis	4.98e-06	5.33e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL6—psoriasis	4.91e-06	5.25e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL6—psoriasis	4.56e-06	4.88e-05	CbGpPWpGaD
